Cargando…
The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronically elevated liver enzymes. Diagnosis and risk stratification of NAFLD remains clinically challenge as patients with NAFLD are either asymptomatic or have nonspecific presenting complaints and may have normal liver enzymes....
Autores principales: | Hernandez Roman, Jose, Siddiqui, Mohammad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576290/ https://www.ncbi.nlm.nih.gov/pubmed/33102796 http://dx.doi.org/10.1002/edm2.127 |
Ejemplares similares
-
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023) -
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023) -
Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013) -
Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013) -
The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease
por: Isabela Andronescu, Craita, et al.
Publicado: (2018)